Episode #5: Cancer Research and The Future of Healthcare
December 20, 2021
How do cancer policies differ across the EU and Slovenia? Prevention and early detection. What are the major differences regarding infrastructure for clinical research and trials between US and Slovenia? How will changes in diagnostics and therapeutics likely change policies across countries? How do concerns over privacy affect medical research, and how do approaches on this matter differ between US and EU?
In Episode 5, we talk with ASEF professors Tit Albreht, Robert Jeraj, and Mateja Jamnik. Listen as they discuss research and policymaking in the field of healthcare, with an emphasis on cancer research and prevention.
- Tit Albreht, is an Associate Professor of Public Health at the Faculty of Medicine, University of Ljubljana, and a member of the Scientific Committee of the European Public Health Association. Since 2006, he has been actively involved in the development of cancer policies at the European level – during the Slovenian Presidency of the European Council and later as coordinator of Joint Actions on cancer policy at the European Union level, including the European Partnership for Action Against Cancer (EPAAC), Cancer Control (CanCon) and most recently, the Innovative Partnership for Action Against Cancer (iPAAC).
- Robert Jeraj, is a Professor of Medical Physics, Human Oncology, Radiology, and Biomedical Engineering at the University of Wisconsin, Madison, where he leads the Imaging and Radiation Sciences Program at the University of Wisconsin Carbone Cancer Center. He is also a professor at the University of Ljubljana, where he leads a team related to medical physics, and oncology.
- Mateja Jamnik, is a Professor of Artificial Intelligence in the Department of Computer Science and Technology (Computer Laboratory) at the University of Cambridge, UK. She is an associate fellow at the Leverhulme Centre for the Future of Intelligence and recently served as Specialist Adviser to the House of Lords Select Committee on Artificial Intelligence. She is also a SMUL (World Network of the University of Ljubljana) council member. Among other topics, her research focuses on applying AI technology to medical data to advance personalized cancer medicine.
The ASEF Podcast host is Tanja Janko, a Master's Student of Chemistry at the University of Zurich. She was an ASEF Fellow in 2019 with Dr. Dimitri Krainc at Northwestern University.